TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics.
More Information Supplier PagePyridostatin is a G-quadruplex-interacting drug which can promote growth arrest in human cancer cells by inducing replication- and transcription-dependent DNA damage.
More Information Supplier PagePyridostatin is a G-quadruplex-interacting drug which can promote growth arrest in human cancer cells by inducing replication- and transcription-dependent DNA damage.
More Information Supplier PagePyridostatin is a G-quadruplex-interacting drug which can promote growth arrest in human cancer cells by inducing replication- and transcription-dependent DNA damage.
More Information Supplier PageGDC-0834 is a potent and selective inhibitor of Bruton’s tyrosine kinase (BTK), investigated as a potential treatment for rheumatoid arthritis.
More Information Supplier PageGDC-0834 is a potent and selective inhibitor of Bruton’s tyrosine kinase (BTK), investigated as a potential treatment for rheumatoid arthritis.
More Information Supplier PagePHCCC is a group I metabotropic glutamate receptor antagonist (IC50 ~ 3 ??M).
More Information Supplier PagePHCCC is a group I metabotropic glutamate receptor antagonist (IC50 ~ 3 ??M).
More Information Supplier PagePHCCC is a group I metabotropic glutamate receptor antagonist (IC50 ~ 3 ??M).
More Information Supplier PagePHCCC is a group I metabotropic glutamate receptor antagonist (IC50 ~ 3 ??M).
More Information Supplier Page
